ArticleMolecular biology reports2026
Molecular and functional interplay of prostaglandin F2 alpha and oxytocin in camel corpus luteum using in vitro model.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the molecular and functional mechanisms of luteolysis in the mature camel corpus luteum (CL) in response to prostaglandin F METHODS AND
resultsCL from mature she-camel were obtained and in vitro cultured in a modified media, then subjected to hormonal treatments for 24 h, including prostaglandin (PFG; 1000 µM), oxytocin (OXT; 300 IU), or a combination thereof. The collected CL underwent RNA isolation and subsequent qRT-PCR analysis to assess the expression of key luteolytic genes: PTGFR, FASLG, and OXTR. Progesterone (P4) concentrations in the culture media were determined, and histological examinations were performed on the CL tissues. PGF treatment alone induced potent luteolysis, characterized by a significant reduction in P4 concentration (from 18.33 ± 2.85 to 5.44 ± 1.58 ng/mL), severe structural degeneration, and a marked four-fold upregulation of PTGFR and FASLG mRNA transcripts. Furthermore, OXT alone had no significant effect on P4 levels or gene expression. Crucially, the co-administration of PGF and OXT resulted in striking functional-structural dissociation: P4 secretion was maintained at control levels (18.43 ± 4.75 ng/mL), and the PGF-induced upregulation of PTGFR and FASLG was significantly attenuated (two-fold increase).
conclusionOXT exerts a novel anti-luteolytic effect by interfering with the PGF-mediated molecular cascade, while the combination may simultaneously trigger a rapid, non-apoptotic structural collapse. This dissociation highlights a robust compensatory mechanism in the camel CL and suggests a potential therapeutic strategy for controlled luteal regression in camel breeding programs.
Indexed as
Identifiers
42911465What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.